These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 18820778)

  • 1. Heparin quality control in the Brazilian market: implications in the cardiovascular surgery.
    Melo EI; Pereira MS; Cunha RS; Sá MP; Mourão PA
    Rev Bras Cir Cardiovasc; 2008; 23(2):169-74. PubMed ID: 18820778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Composition of OSCS-contaminated heparin occurring in 2008 in batches on the German market.
    Beyer T; Matz M; Brinz D; Rädler O; Wolf B; Norwig J; Baumann K; Alban S; Holzgrabe U
    Eur J Pharm Sci; 2010 Jul; 40(4):297-304. PubMed ID: 20399266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of established and novel purity tests for the quality control of heparin by means of a set of 177 heparin samples.
    Alban S; Lühn S; Schiemann S; Beyer T; Norwig J; Schilling C; Rädler O; Wolf B; Matz M; Baumann K; Holzgrabe U
    Anal Bioanal Chem; 2011 Jan; 399(2):605-20. PubMed ID: 20824424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel method for the determination of average molecular weight of natural polymers based on 2D DOSY NMR and chemometrics: Example of heparin.
    Monakhova YB; Diehl BWK; Do TX; Schulze M; Witzleben S
    J Pharm Biomed Anal; 2018 Feb; 149():128-132. PubMed ID: 29112901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the USP heparin monograph and implications for clinicians.
    Smythe MA; Nutescu EA; Wittkowsky AK
    Pharmacotherapy; 2010 May; 30(5):428-31. PubMed ID: 20411994
    [No Abstract]   [Full Text] [Related]  

  • 6. Lessons from contaminated heparin.
    Dodd S; Besag FM
    Curr Drug Saf; 2009 Jan; 4(1):1. PubMed ID: 19149518
    [No Abstract]   [Full Text] [Related]  

  • 7. Potentiality of proton nuclear magnetic resonance and multivariate calibration methods for the determination of dermatan sulfate contamination in heparin samples.
    Ruiz-Calero V; Saurina J; Galceran MT; Hernández-Cassou S; Puignou L
    Analyst; 2000 May; 125(5):933-8. PubMed ID: 10885058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The troubled heparin issue in the Brazilian market and the search for solutions.
    Gomes WJ; Braile DM
    Rev Bras Cir Cardiovasc; 2009; 24(2):3-4. PubMed ID: 19768285
    [No Abstract]   [Full Text] [Related]  

  • 9. Heparin pharmacovigilance in Brazil.
    Junqueira DR; Viana TG; Peixoto ER; Barros FC; Carvalho Md; Perini E
    Rev Assoc Med Bras (1992); 2011; 57(3):322-6. PubMed ID: 21691698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of heparin samples that contain impurities or contaminants by chemometric pattern recognition analysis of proton NMR spectral data.
    Zang Q; Keire DA; Buhse LF; Wood RD; Mital DP; Haque S; Srinivasan S; Moore CM; Nasr M; Al-Hakim A; Trehy ML; Welsh WJ
    Anal Bioanal Chem; 2011 Aug; 401(3):939-55. PubMed ID: 21678118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of unfractionated heparin: comparison of materials from the last 50 years.
    Mulloy B; Gray E; Barrowcliffe TW
    Thromb Haemost; 2000 Dec; 84(6):1052-6. PubMed ID: 11154113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of circular dichroism as a simple heparin-screening strategy.
    Stanley FE; Stalcup AM
    Anal Bioanal Chem; 2011 Jan; 399(2):701-6. PubMed ID: 20953771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining (1)H NMR spectroscopy and chemometrics to identify heparin samples that may possess dermatan sulfate (DS) impurities or oversulfated chondroitin sulfate (OSCS) contaminants.
    Zang Q; Keire DA; Wood RD; Buhse LF; Moore CM; Nasr M; Al-Hakim A; Trehy ML; Welsh WJ
    J Pharm Biomed Anal; 2011 Apr; 54(5):1020-9. PubMed ID: 21215547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tainted heparin crisis tested FDA's investigative skills.
    Lavine G
    Am J Health Syst Pharm; 2009 Feb; 66(3):210-1. PubMed ID: 19179633
    [No Abstract]   [Full Text] [Related]  

  • 15. One-dimensional cellulose acetate plate electrophoresis--a feasible method for analysis of dermatan sulfate and other glycosaminoglycan impurities in pharmaceutical heparin.
    Domanig R; Jöbstl W; Gruber S; Freudemann T
    J Pharm Biomed Anal; 2009 Jan; 49(1):151-5. PubMed ID: 19062213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining NMR Spectroscopy and Chemometrics to Monitor Structural Features of Crude Hep-arin.
    Mauri L; Marinozzi M; Mazzini G; Kolinski RE; Karfunkle M; Keire DA; Guerrini M
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28698456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assays and reference materials for current and future applications of heparins.
    Mulloy B; Hogwood J; Gray E
    Biologicals; 2010 Jul; 38(4):459-66. PubMed ID: 20338781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant woman and her fetus.
    Andrew M; Mitchell L; Berry L; Paes B; Delorme M; Ofosu F; Burrows R; Khambalia B
    J Clin Invest; 1992 Jan; 89(1):321-6. PubMed ID: 1729278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of endogenous anticoagulant N-sulfated glycosaminoglycans in human plasma from healthy subjects.
    Ruggiero M; Melli M; Parma B; Bianchini P; Vannucchi S
    Pathophysiol Haemost Thromb; 2002; 32(1):44-9. PubMed ID: 12214163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular profiling of heparinase-I resistant glycosaminoglycans in contaminated heparins. Comparative studies with uncontaminated heparin and porcine oversulfated chondroitin sulfate.
    Clark M; Hoppensteadt D; Walenga J; Myers L; Cunanan J; Jeske W; Adiguzel C; Iqbal O; Fareed J
    Int Angiol; 2008 Oct; 27(5):370-6. PubMed ID: 18974698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.